All Stories

  1. Clinical Application of Thiopurine Pharmacogenomics in Pediatrics
  2. Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease
  3. Pharmacogenetics of treatments for inflammatory bowel disease
  4. Targeting Kinase-activating Genetic Lesions to Improve Therapy of Pediatric Acute Lymphoblastic Leukemia
  5. Induced Pluripotent Stem Cells as a Model for Therapy Personalization of Pediatric Patients: Disease Modeling and Drug Adverse Effects Prevention
  6. Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease
  7. Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease
  8. Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy
  9. In vitrosensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome
  10. Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance
  11. Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response